drugset / Trial / NCT00103454

A Study To Evaluate The Efficacy And Safety Of A Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR).

NCT00103454

Phase 3 Completed 288 enrolled GlaxoSmithKline
RandomizedParallel-groupDouble-blindTreatment

Summary

The primary objective of this study is to compare the efficacy and safety of GW685698X 100mcg once daily (QD) aqueous nasal spray with vehicle placebo nasal spray in adult and adolescent subjects (12 years of age and older) with perennial allergic rhinitis (PAR).

Timeline

Start
2005-01
Primary completion
2005-05
Completion
2005-05

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluticasone Furoate Other / unclassified 100 ug Intranasal